Article Detail - JE Part B
MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer (L37897) - R4 - Effective October 14, 2021
Date Posted: October 9, 2025
This MolDX Local Coverage Determination (LCD) has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
Effective Date: October 14, 2021
Summary of Changes:
Under Issue Description: Formatting, punctuation, and typographical errors were corrected. Under Coverage Indications, Limitations and/or Medical Necessity: Formatting, punctuation, and typographical errors were corrected.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCD or access it via the CMS Medicare Coverage Database (MCD).